0001944154-25-000001.txt : 20250829 0001944154-25-000001.hdr.sgml : 20250829 20250829114319 ACCESSION NUMBER: 0001944154-25-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20250829 DATE AS OF CHANGE: 20250829 EFFECTIVENESS DATE: 20250829 FILER: COMPANY DATA: COMPANY CONFORMED NAME: R-Bridge Healthcare Fund II, L.P. CENTRAL INDEX KEY: 0001944154 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-522586 FILM NUMBER: 251277964 BUSINESS ADDRESS: STREET 1: C/O MAPLES CORPORATE SERVICES LIMITED STREET 2: PO BOX 309, UGLAND HOUSE CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: 65 69228413 MAIL ADDRESS: STREET 1: C/O MAPLES CORPORATE SERVICES LIMITED STREET 2: PO BOX 309, UGLAND HOUSE CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 D/A 1 primary_doc.xml X0708 D/A LIVE 0001944154 R-Bridge Healthcare Fund II, L.P. C/O MAPLES CORPORATE SERVICES LIMITED BOX 309, UGLAND HOUSE GRAND CAYMAN E9 CAYMAN ISLANDS KY1-1104 852 5599 0951 CAYMAN ISLANDS None None Limited Partnership true 2022 Fu Wei 88 Market Street #46-04/05 Capitaspring Singapore U0 SINGAPORE 048948 Director Director of the general partner of the Issuer Jianming Ma Floor 62, Tower 1, Plaza 66 1266 West Nanjing Road Shanghai F4 CHINA 200040 Director Director of the general partner of the Issuer Pooled Investment Fund Other Investment Fund false Decline to Disclose 06b 3C 3C.1 3C.7 true 0001944154-24-000002 2024-08-29 false true true false 0 Indefinite 50000000 Indefinite false 1 0 0 0 true The general partner (or its affiliates) is entitled to a performance allocation and a management fee. The performance allocation and management fee are fully discussed in the Issuer's confidential offering materials. false R-Bridge Healthcare Fund II, L.P. Fu Wei Fu Wei Director of the general partner of the Issuer 2025-08-29